# MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

> **NCT07541404** · NA · NOT_YET_RECRUITING · sponsor: **Arsenal Medical, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Subdural Hematoma

## Interventions

- **DEVICE:** NeoCast Embolic System
- **DEVICE:** FDA-Approved Commercial Liquid Embolic

## Key facts

- **NCT ID:** NCT07541404
- **Lead sponsor:** Arsenal Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-11
- **Final completion:** 2028-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07541404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07541404, "MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07541404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*